<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B75CE818-8A4C-4ACA-82E2-C952425212B2"><gtr:id>B75CE818-8A4C-4ACA-82E2-C952425212B2</gtr:id><gtr:name>Brainshake</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Public Health and Primary Care</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B75CE818-8A4C-4ACA-82E2-C952425212B2"><gtr:id>B75CE818-8A4C-4ACA-82E2-C952425212B2</gtr:id><gtr:name>Brainshake</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2A11538A-4A54-4A63-AB9F-BDB95AD7D61C"><gtr:id>2A11538A-4A54-4A63-AB9F-BDB95AD7D61C</gtr:id><gtr:firstName>Elio</gtr:firstName><gtr:surname>Riboli</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EB134AF9-197A-4970-8C8E-6D9132EBEB02"><gtr:id>EB134AF9-197A-4970-8C8E-6D9132EBEB02</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Ian</gtr:otherNames><gtr:surname>McCarthy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/161DE809-8AE4-4978-9F68-F106C8C63ED0"><gtr:id>161DE809-8AE4-4978-9F68-F106C8C63ED0</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Wareham</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4B98F259-77FE-4FC0-9296-140C9C066977"><gtr:id>4B98F259-77FE-4FC0-9296-140C9C066977</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Danesh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D4875E5B-C2B2-4BB4-BA70-E1170A00D2A7"><gtr:id>D4875E5B-C2B2-4BB4-BA70-E1170A00D2A7</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Thompson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/95F764B3-B980-4210-87D7-B24034F7540A"><gtr:id>95F764B3-B980-4210-87D7-B24034F7540A</gtr:id><gtr:firstName>Leena</gtr:firstName><gtr:surname>Peltonen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D966BB61-3D36-4457-A5A8-2DE10449224D"><gtr:id>D966BB61-3D36-4457-A5A8-2DE10449224D</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Elliott</gtr:surname><gtr:orcidId>0000-0002-7511-5684</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C68F5417-E9B6-4D41-A185-16D809E144FD"><gtr:id>C68F5417-E9B6-4D41-A185-16D809E144FD</gtr:id><gtr:firstName>Petra</gtr:firstName><gtr:otherNames>Huberdina</gtr:otherNames><gtr:surname>Peeters</gtr:surname><gtr:orcidId>0000-0001-9030-8655</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800270"><gtr:id>B49E45DD-B634-4825-9FD7-E75D0BAF95CA</gtr:id><gtr:title>Study of the interplay of genetic, biochemical, and lifestyle factors on coronary heart disease incidence</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800270</gtr:grantReference><gtr:abstractText>Heart disease is the single leading killer in the UK and globally, is responsible for considerable disability, and involves several important modifiable risk factors, such as smoking, diabetes, and elevated levels of cholesterol and blood pressure. 

The occurrence of heart attacks depends on the complex interplay of genetic make-up, environmental factors and chance. Understanding the interplay of ?nature? and ?nurture? in heart disease should contribute to important advances in: (i) explaining the biological chain of events that leads to a heart attack, (ii) effectively targeting existing measures to prevent disease, and (iii) developing lifestyle programmes for people to counteract disadvantageous genetic profiles. 

Until recently, it has been difficult to study the interplay of genes, biochemical factors and lifestyles (eg, dietary habits and physical activity) in CHD. Medical surveys have tended to be too small, insufficiently detailed, inappropriately designed, or had some combination of these limitations. Also, it is only in the past few years that genetic research has identified a reasonably large number of genetic factors related to heart disease and relevant characteristics (such as levels of blood fats, obesity and diabetes). 

The current research project seeks to conduct a large and detailed study of genetic, biochemical and lifestyle factors in heart disease by using an existing survey of over 500,000 middle-aged Europeans living in ten countries. Starting in the early 1990s, initially healthy participants gave blood, replied to questionnaires (eg, about lifestyles, habits) and provided physical measurements. These individuals have now been monitored for over a decade on average, during which time more than 10,000 people have had heart attacks. It is proposed to conduct genetic and biochemical tests in the stored samples of 10,000 patients with confirmed heart disease and in 10,000 controls who have remained free of heart disease. 

Genetic and biochemical information assessed in these individuals will then be collated with information on smoking habits, diet, physical activity and other characteristics previously recorded at the initial visit to create a rich and powerful database. This database will be carefully harvested to yield a series of immediate and longer-term findings of major international importance for the understanding, prediction and prevention of heart disease.</gtr:abstractText><gtr:technicalSummary>A strategic award is sought, jointly from the MRC and BHF, to enable large-scale investigation of the separate and combined influences of genetic, biochemical and major lifestyle factors (notably diet) on the incidence of coronary heart disease (CHD) in an existing large population-based prospective study across Europe. Reliable evaluation of the interplay of these factors should substantially advance understanding of the aetiology of CHD and contribute to prevention strategies, such as optimum targeting of interventions and identification of novel therapeutic targets. EPIC-Heart is in an excellent position to provide rapid, reliable and cost-effective studies of the combination of genetic, biochemical, and lifestyle factors because it has already: 

1) recorded, in a standardised and prospective manner, information on diet, physical activity and other lifestyle characteristics in almost 520,000 mostly middle-aged Europeans from 10 countries (with over ?100M invested to date to establish and maintain this cohort) 
2) collected and stored biological material to enable analyses of DNA, plasma and red cells 
3) accrued over 10,000 cases of incident CHD during over 5 million person-years of follow-up 
4) verified in a substudy that almost 90% of the patients in EPIC with suspected CHD fulfil standard criteria, and 
5) agreed and published a scientific plan and study management arrangements. 

EPIC-Heart will achieve further efficiency by utilising the 10,000 controls in the EPIC-InterAct case-cohort study of gene-lifestyle interactions in type 2 diabetes. InterAct has already been funded and will assay some risk markers of potential shared relevance to diabetes and CHD. Strategic support is sought, therefore, to enable an efficient case-cohort study of genetic, biochemical and lifestyle factors in CHD involving about 10,000 confirmed incident cases and 10,000 controls. This will entail: ascertainment and verification of CHD cases; retrieval of stored samples; extraction and preparation of DNA; focused genetic and biochemical assays; statistical analyses; and studies of implications of findings for clinical practice and population health. In addition to generating a series of exceptionally informative findings that address major current hypotheses in CHD, this initiative will create a unique resource for future investigations.</gtr:technicalSummary><gtr:fund><gtr:end>2015-01-04</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-07-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2977135</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Global R &amp; D</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>195C86CD-2520-4B04-B884-1B602F3D6D15</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5464c5d8451138.26104806-6</gtr:outcomeId><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>E9564921-04D3-41B6-BC0E-376B863DF9DA</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5464c5d8451138.26104806-3</gtr:outcomeId><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard T.H. Chan School of Public Health</gtr:department><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>EE3BBC2D-E5D8-4D7E-A3D4-36B92908B490</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5464c5d8451138.26104806-1</gtr:outcomeId><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>6B10B1EB-4B6F-4FC1-813E-DD616CF84749</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5464c5d8451138.26104806-7</gtr:outcomeId><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>6B2A141E-D3FD-4A88-A944-AF226A19C824</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5464c5d8451138.26104806-5</gtr:outcomeId><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>7B3C45D1-9333-47B3-B362-991FACDF5327</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5464c5d8451138.26104806-2</gtr:outcomeId><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>DBC01BEE-4C42-49F7-9C73-BD55927F5271</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5464c5d8451138.26104806-4</gtr:outcomeId><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brainshake</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:description>NMR Metabolomics</gtr:description><gtr:id>86CFAC75-5586-44E4-87A3-687EAD028FED</gtr:id><gtr:impact>Publication manuscripts in preparation</gtr:impact><gtr:outcomeId>56e1543c5454e1.50676110-1</gtr:outcomeId><gtr:partnerContribution>Assays complete for all 50,000 samples, ~240 metabolites measured.</gtr:partnerContribution><gtr:piContribution>Provided samples from 50,000 participants in INTERVAL study.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation at BRC Scientific Advisory Board</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>54CC5DA1-939F-49CF-BD98-12FE2E285F2D</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:outcomeId>56e16b573d8683.67415257</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the European Bioinformatics Institute</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>97695A98-223A-473B-9462-61DFAE59EF56</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:outcomeId>56e16aface32d4.43566734</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to Takeda</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B925D257-A8DB-4335-B59F-BF554C5E5779</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:outcomeId>56e16b7df19383.71823836</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alan Turing Institute presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>31301DA0-24FC-426D-88B3-9610D38A5B5E</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:outcomeId>56e16a13ae8596.09750527</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>187110DE-9A34-4F5B-8671-41DABC90EDA0</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:outcomeId>56e16ac4310891.38941565</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Collaborative workshop MRC Biostatistics</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>749EDFF9-ACB3-4B0B-8E75-EE59383C1DFE</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:outcomeId>56e16ba5884f19.27173362</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at Wellcome Trust Target Validation Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>02344177-67E3-4ECA-BF6D-703C67A11B30</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:outcomeId>56cdcb8bbefac8.63463042</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at AstraZeneca</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FBF7B54B-4011-415E-8C35-83A31BC8B9ED</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:outcomeId>56e168c235f312.08615174</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at BHF Centre of Excellence meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>20A5BA80-BDC3-48E8-B7CC-3994140DC189</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:outcomeId>56e16985bf14e8.98315480</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EPIC-CVD (Framework Programme 7 - Health)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>79CE2148-ED7B-4C43-8D61-928D9B3CC92F</gtr:id><gtr:outcomeId>FP4Z54VVSpE</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4099619</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Blood Transplant Research Unit (NIHR - BTRU)</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>F37600DC-48BF-4A88-BCB1-88C3607CBAF0</gtr:id><gtr:outcomeId>5464ba78270929.38436171</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2499154</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>European Research Council Advanced Investigator Award (EPIC Heart)</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>42F23F91-9CF9-4895-9A6A-4AED7C4E133A</gtr:id><gtr:outcomeId>faEScK8Uyb2</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Metabochip Consortium database</gtr:description><gtr:id>A0E599F1-A8A1-48C7-A859-72776534B1C2</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5464c0da0716b6.66802338</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Metabochip Consortium</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Data have been collected and harmonised on 25,000 individuals</gtr:description><gtr:id>8431651F-D1E2-4801-BEF8-46F47977FADD</gtr:id><gtr:impact>No impact as yet</gtr:impact><gtr:outcomeId>546494012d79c9.41219287</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EPIC-Heart Database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>The EPIC-Heart phenotype database is being expanded to stroke outcomes (~9000 incident cases), rather than just coronary disease, adding further value to the initial investment</gtr:description><gtr:id>1DB8F071-91DD-48B9-AB45-17804E9E63FE</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54649468d2fdd1.08952565</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EPIC-CVD database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Exome chip consortium</gtr:description><gtr:id>67860CC8-4F3D-49CC-ACE8-BC413E272B44</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5464c09e948615.57386488</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Exome Chip Consortium</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>To allow the assessment of risk prediction in a multi-centre case-cohort study, novel statistical methods have been developed at the EPIC-Heart Coordinating Centre</gtr:description><gtr:id>AB87C5A0-563D-431E-B27A-B8B1F228B591</gtr:id><gtr:impact>A Publication: &amp;quot;Derivation and assessment of risk prediction models using case-cohort data&amp;quot;. Sanderson J, Thompson SG, White IR, Aspelund T, Pennells L. BMC Med Res Methodol. 2013 Sep 13;13(1):113</gtr:impact><gtr:outcomeId>bqwubQg2Rgr</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Methods</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Assays have now been completed in all EPIC-Heart participants on the following phenotypes:
- 22 clinical chemistry biomarkers
- 210,000 genetic variants
- a further 450,000 genetic variants
- a panel of 37 fatty acids

Assays are near completion in these participants for vitamins C and D, a panel of 6 carotenoids and telomere length. These assays are also being extended to stroke cases identified under the FP7 funded project, EPIC-CVD, adding further value to the EPIC-Heart project.</gtr:description><gtr:id>42F3665B-8F44-4F19-ABD0-276F47E17B5D</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>nirJ3cgSm8E</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EPIC-Heart Assays</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3285A261-34DD-4EB7-9E37-76DE51CDE8A0</gtr:id><gtr:title>Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/360a808324aad78098cb2db35a75a186"><gtr:id>360a808324aad78098cb2db35a75a186</gtr:id><gtr:otherNames>Haycock PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5a3100028ce152.24841045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF97F749-C5CB-4C9E-9E2E-B749025E95D4</gtr:id><gtr:title>Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e4c220c3b3958f29fccb7c03f12eb86"><gtr:id>4e4c220c3b3958f29fccb7c03f12eb86</gtr:id><gtr:otherNames>Interleukin 1 Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>56e032f21e34c1.10911448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58D2C0B2-C91A-4B0B-8F3A-C0908CCB2B54</gtr:id><gtr:title>Association analyses based on false discovery rate implicate new loci for coronary artery disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27ab42a94bafa274f6486233c637c714"><gtr:id>27ab42a94bafa274f6486233c637c714</gtr:id><gtr:otherNames>Nelson CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a34f399e01190.52661959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B384AE4C-F3BA-49FF-9F01-9B128A039D82</gtr:id><gtr:title>Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ecb2281513a936a91957e04ee639286"><gtr:id>8ecb2281513a936a91957e04ee639286</gtr:id><gtr:otherNames>Franco OH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>58c14c26c6daa5.71401821</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DD11816-13F1-4C05-B6FC-CAD6E565BEAF</gtr:id><gtr:title>Assessing risk prediction models using individual participant data from multiple studies.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06604b6e3b810c3a3d29dc9dc30fa1d9"><gtr:id>06604b6e3b810c3a3d29dc9dc30fa1d9</gtr:id><gtr:otherNames>Pennells L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>56e03667d07528.78054484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05DE7677-033E-4E67-952A-8CAE022278B8</gtr:id><gtr:title>Accuracy of Patient Self-Report of Stroke: A Systematic Review from the UK Biobank Stroke Outcomes Group.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc177bc67084e61937ac7f2b418f0334"><gtr:id>bc177bc67084e61937ac7f2b418f0334</gtr:id><gtr:otherNames>Woodfield R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e032e755b356.42123885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10C01405-95E0-45B4-B724-F43853DB0C35</gtr:id><gtr:title>Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e7b9f88de7989208d17352d3514ca24"><gtr:id>1e7b9f88de7989208d17352d3514ca24</gtr:id><gtr:otherNames>Bowden J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn><gtr:outcomeId>58c14e289b44e3.68510073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ADD25BE-8D85-4371-8882-765A7250A5EE</gtr:id><gtr:title>A Procedure for Deriving Formulas to Convert Transition Rates to Probabilities for Multistate Markov Models.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e050bd6475c7c807ec5722cb9a2cc56"><gtr:id>7e050bd6475c7c807ec5722cb9a2cc56</gtr:id><gtr:otherNames>Jones E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>5a2fdbd1ae8a15.41269611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80B8EDC6-230B-4FBC-8548-22AA98F8CABE</gtr:id><gtr:title>Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e724be049eb36843b02b64126be3760"><gtr:id>4e724be049eb36843b02b64126be3760</gtr:id><gtr:otherNames>Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>58c156762282a8.06832261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A813EF9-6DEA-441D-841A-102F38D16AED</gtr:id><gtr:title>A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad517b46218a425c2709298b75184e34"><gtr:id>ad517b46218a425c2709298b75184e34</gtr:id><gtr:otherNames>Stritt S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>58c14c269c48f2.76450610</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7289EA49-823A-4B54-BE6B-025880A2F675</gtr:id><gtr:title>Socioeconomic Deprivation and Survival After Heart Transplantation in England: An Analysis of the United Kingdom Transplant Registry.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular quality and outcomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40d98d0d2b382445c41bf8f9c7fc28dc"><gtr:id>40d98d0d2b382445c41bf8f9c7fc28dc</gtr:id><gtr:otherNames>Evans JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1941-7713</gtr:issn><gtr:outcomeId>58c14ca98b6a50.89497278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF3D7ED4-A1EA-4F8A-ABB2-6DCA236E2A3E</gtr:id><gtr:title>Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.</gtr:title><gtr:parentPublicationTitle>Current opinion in endocrinology, diabetes, and obesity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1752-296X</gtr:issn><gtr:outcomeId>58c14d968505a7.26795233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C338A68A-6119-4D49-942C-75DF30130983</gtr:id><gtr:title>Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cf8ebbb626acee433700d8f65aab007"><gtr:id>7cf8ebbb626acee433700d8f65aab007</gtr:id><gtr:otherNames>Iotchkova V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58c1567569d852.85287672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B6CA84C-0BFC-4B2E-BFDC-0F4198A6333E</gtr:id><gtr:title>Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/590c8a9618b273cc7c1e0848dd49db27"><gtr:id>590c8a9618b273cc7c1e0848dd49db27</gtr:id><gtr:otherNames>Lotta LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>58c15675905271.29759450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E366D70B-146D-4CB4-8B30-7F5F66A0C5C3</gtr:id><gtr:title>Donor understandings of blood and the body in relation to more frequent donation.</gtr:title><gtr:parentPublicationTitle>Vox sanguinis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/943baaeb29c818651246c7cdaf4cd271"><gtr:id>943baaeb29c818651246c7cdaf4cd271</gtr:id><gtr:otherNames>Lynch R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0042-9007</gtr:issn><gtr:outcomeId>5a995f0da52f39.38139257</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6BA42B8-4DA1-4B44-B14A-A847C342A453</gtr:id><gtr:title>Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6239da935471ebe92e7c1c0a9617342b"><gtr:id>6239da935471ebe92e7c1c0a9617342b</gtr:id><gtr:otherNames>Imamura M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d53a80b58c4.80008654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD6F5BE2-EBFC-488C-8CB4-EBBB57D13E53</gtr:id><gtr:title>Using predictions from a joint model for longitudinal and survival data to inform the optimal time of intervention in an abdominal aortic aneurysm screening programme.</gtr:title><gtr:parentPublicationTitle>Biometrical journal. Biometrische Zeitschrift</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c22c62d0cf7146e7a5119404c7ca83"><gtr:id>08c22c62d0cf7146e7a5119404c7ca83</gtr:id><gtr:otherNames>Sweeting MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0323-3847</gtr:issn><gtr:outcomeId>5a2fd7979c9b34.92609726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A7A7343-54C9-4EC7-AAB9-BA373A9B02DD</gtr:id><gtr:title>Meta-analysis of the current prevalence of screen-detected abdominal aortic aneurysm in women.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55c6610e962d2491862cbf81fc60d707"><gtr:id>55c6610e962d2491862cbf81fc60d707</gtr:id><gtr:otherNames>Ulug P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn><gtr:outcomeId>58c14e2944fa79.59040941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ABB4F0B-9103-4DC8-AD81-9CA8BB8B2D52</gtr:id><gtr:title>eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/366870b4b9c4e0bc2e3adff3feb2d866"><gtr:id>366870b4b9c4e0bc2e3adff3feb2d866</gtr:id><gtr:otherNames>Breeze CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c14cfa9cf070.59782277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B967DDB-8296-4CB4-B0B2-20276363D86A</gtr:id><gtr:title>Cardiovascular disease risk by assigned treatment using the 2013 and 1998 obesity guidelines.</gtr:title><gtr:parentPublicationTitle>Obesity (Silver Spring, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bef6f03e1cdc8eff88441b13925befab"><gtr:id>bef6f03e1cdc8eff88441b13925befab</gtr:id><gtr:otherNames>Stevens J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1930-7381</gtr:issn><gtr:outcomeId>58c14e28e5a517.12005739</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B508780D-0A5C-4218-A6D2-A647E6090D8E</gtr:id><gtr:title>Validation of self-administered nasal swabs and postage for the isolation of Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>Journal of medical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dec748caea258ba8ff00a61a2245c890"><gtr:id>dec748caea258ba8ff00a61a2245c890</gtr:id><gtr:otherNames>Harrison EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2615</gtr:issn><gtr:outcomeId>58c15675b4e475.72751207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED7ACC8B-20B7-4E5F-9A77-A827070829E3</gtr:id><gtr:title>Interventions to reduce vasovagal reactions in blood donors: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Transfusion medicine (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08112693a12b70debb270f3297d29147"><gtr:id>08112693a12b70debb270f3297d29147</gtr:id><gtr:otherNames>Fisher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0958-7578</gtr:issn><gtr:outcomeId>58c15676007824.29248778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>879FFC66-4D09-40CC-BBBD-59F75CD1CBDE</gtr:id><gtr:title>The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3227fce97d99562f294f215341e71f74"><gtr:id>3227fce97d99562f294f215341e71f74</gtr:id><gtr:otherNames>Astle WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>585d33ba1d55d4.11788017</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF14F775-22B7-41D2-9169-6FD6BE8C9F53</gtr:id><gtr:title>Serum gamma-glutamyl transferase and risk of type 2 diabetes in the general Korean population: a Mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb04737da24f4df127b02dabcb33fd7c"><gtr:id>fb04737da24f4df127b02dabcb33fd7c</gtr:id><gtr:otherNames>Lee YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58c14c26e2dea8.65064486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B54A2FD-23FD-4813-913C-01BA30A8788B</gtr:id><gtr:title>The use of repeated blood pressure measures for cardiovascular risk prediction: a comparison of statistical models in the ARIC study.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c22c62d0cf7146e7a5119404c7ca83"><gtr:id>08c22c62d0cf7146e7a5119404c7ca83</gtr:id><gtr:otherNames>Sweeting MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>58c14ca946d126.71860825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FED81ED-677F-4349-891D-64394B28E0E8</gtr:id><gtr:title>Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7a1e6c1d76e70702a15effb81f63589"><gtr:id>b7a1e6c1d76e70702a15effb81f63589</gtr:id><gtr:otherNames>Liu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58c15675057f76.35238397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E6DD0A5-038C-471A-A1E3-CAFB48A32B3D</gtr:id><gtr:title>Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7e395f3d1d4bf26598536bd293a9e4b"><gtr:id>f7e395f3d1d4bf26598536bd293a9e4b</gtr:id><gtr:otherNames>Podmore C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>56e0324b8451d8.41928363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44A1C9D7-71DE-4129-B64E-E5B86A4CF420</gtr:id><gtr:title>Genome-wide analysis of differential transcriptional and epigenetic variability across human immune cell types.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/143248c4598dc867388824b7cee95b90"><gtr:id>143248c4598dc867388824b7cee95b90</gtr:id><gtr:otherNames>Ecker S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5a2fda7db5f442.92612178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C65924D-3945-454B-B74A-D3B525B61345</gtr:id><gtr:title>The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39d81fbd907266340cd711bbb9b2eac5"><gtr:id>39d81fbd907266340cd711bbb9b2eac5</gtr:id><gtr:otherNames>Wen KX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c14b8d0db9c4.24125561</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>342B290B-AD01-4D6B-8AC6-8EF1CCC4C560</gtr:id><gtr:title>Derivation and assessment of risk prediction models using case-cohort data.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d9829eb284f15497e3e21d2a57302b4"><gtr:id>2d9829eb284f15497e3e21d2a57302b4</gtr:id><gtr:otherNames>Sanderson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>56e0366bddafd4.88909633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56EA9576-4169-473E-8193-FBFF78CC4AD3</gtr:id><gtr:title>Association of Cardiometabolic Multimorbidity With Mortality.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00954130f581451305ebfe461866731f"><gtr:id>00954130f581451305ebfe461866731f</gtr:id><gtr:otherNames>Emerging Risk Factors Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>56e032e8cbfb27.56966108</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B18E1FFE-7AE8-4F1E-810A-E656D8BD2597</gtr:id><gtr:title>Parity, breastfeeding and risk of coronary heart disease: A pan-European case-cohort study.</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7daee98c7d288fe9d8420024484dc3e"><gtr:id>b7daee98c7d288fe9d8420024484dc3e</gtr:id><gtr:otherNames>Peters SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn><gtr:outcomeId>58c156752d3287.89634484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE3BB64C-8B96-447A-AA5B-5D34087922D6</gtr:id><gtr:title>Quantitative comparison of DNA methylation assays for biomarker development and clinical applications.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a822f18b8876dbf1bf41afea4b2e8e98"><gtr:id>a822f18b8876dbf1bf41afea4b2e8e98</gtr:id><gtr:otherNames>BLUEPRINT consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>58c14e29143251.11548450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04E16DF3-A6B2-4A3D-96C7-1F8600D775B9</gtr:id><gtr:title>The response to receiving phenotypic and genetic coronary heart disease risk scores and lifestyle advice - a qualitative study.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/156e7519b53a55e0ec3b4fd43928518f"><gtr:id>156e7519b53a55e0ec3b4fd43928518f</gtr:id><gtr:otherNames>Shefer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>5a6da69b6ff980.57641757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3270987C-BA04-4A89-A2CC-2A1CBAD0A041</gtr:id><gtr:title>The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5596e10388755ec63ed3f44030be1b02"><gtr:id>5596e10388755ec63ed3f44030be1b02</gtr:id><gtr:otherNames>Stunnenberg HG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>58c15676681fd2.26774564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EFBB73A-3787-4381-8F36-E37F040D0EB7</gtr:id><gtr:title>Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn><gtr:outcomeId>56e032eef0caa4.23206367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E13080B6-68F0-4F87-89FD-68C88444BC3F</gtr:id><gtr:title>Cord Blood Hepcidin: Cross-Sectional Correlates and Associations with Anemia, Malaria, and Mortality in a Tanzanian Birth Cohort Study.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40fce04c808ecba0ff3bb14f2715b780"><gtr:id>40fce04c808ecba0ff3bb14f2715b780</gtr:id><gtr:otherNames>Brickley EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>58c14ca9181176.00734620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B00C322C-418E-4E8D-BF9E-08A42AD24224</gtr:id><gtr:title>Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>56e03662a5b086.47451591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F03605AA-83F7-4A55-8DDB-E92E638C5168</gtr:id><gtr:title>The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review.</gtr:title><gtr:parentPublicationTitle>Nutrition, metabolism, and cardiovascular diseases : NMCD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea1e5ba889fd0cca140aeff5b41e4684"><gtr:id>ea1e5ba889fd0cca140aeff5b41e4684</gtr:id><gtr:otherNames>Muka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0939-4753</gtr:issn><gtr:outcomeId>58c14e28c12405.18392781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4015CB2B-C000-4769-9CBA-DF2347DA1FB0</gtr:id><gtr:title>A method making fewer assumptions gave the most reliable estimates of exposure-outcome associations in stratified case-cohort studies.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e050bd6475c7c807ec5722cb9a2cc56"><gtr:id>7e050bd6475c7c807ec5722cb9a2cc56</gtr:id><gtr:otherNames>Jones E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>56e032edabd8a0.64122702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C64FCA5-F75C-4910-8861-7AA8C1EC8D2A</gtr:id><gtr:title>A comparison of Cox and logistic regression for use in genome-wide association studies of cohort and case-cohort design.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f01fc7d80dc77023aafc31741f1e082"><gtr:id>4f01fc7d80dc77023aafc31741f1e082</gtr:id><gtr:otherNames>Staley JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>5a31de9f22b542.18373320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0B4DAC8-115D-4942-A54F-C6D135B6B2E1</gtr:id><gtr:title>Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c738f04b064217a6a3e4b8447dddfc9"><gtr:id>6c738f04b064217a6a3e4b8447dddfc9</gtr:id><gtr:otherNames>Usher-Smith JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>56e14c07116c45.62883767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D53633F2-2A30-4EAB-8C59-2717C1F92D10</gtr:id><gtr:title>Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02f4cefb1b43fd90206d810c05991f5d"><gtr:id>02f4cefb1b43fd90206d810c05991f5d</gtr:id><gtr:otherNames>Silarova B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>56e032f311dcb8.42181032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2881AB8A-2B2F-4F0C-80D9-1422B1E31BDF</gtr:id><gtr:title>Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature.</gtr:title><gtr:parentPublicationTitle>The European journal of health economics : HEPAC : health economics in prevention and care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e5ddbd88c7baa76c088b9c1561fcd4e"><gtr:id>1e5ddbd88c7baa76c088b9c1561fcd4e</gtr:id><gtr:otherNames>Epstein D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1618-7598</gtr:issn><gtr:outcomeId>56e03278b89a73.66676459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CC54362-5E1C-4F85-AF16-FFCDABC2D76F</gtr:id><gtr:title>Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn><gtr:outcomeId>58c15675d72353.55654384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB4CA598-CAD9-406E-835E-6976B3B85E2D</gtr:id><gtr:title>Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fc4eefd621187bd6531525a0d279e47"><gtr:id>4fc4eefd621187bd6531525a0d279e47</gtr:id><gtr:otherNames>Surendran P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58c14e29905b54.85869400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D035D72-4EE1-47E1-9FF0-83E4F375E10C</gtr:id><gtr:title>BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86b06e84c16348e51e6de58d42fbcc00"><gtr:id>86b06e84c16348e51e6de58d42fbcc00</gtr:id><gtr:otherNames>Corbin LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>58c14e296dc491.49650611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C8B73CA-2079-4988-96EE-A94C6C1144A5</gtr:id><gtr:title>Genetic invalidation of Lp-PLAas a therapeutic target: Large-scale study of five functional Lp-PLA-lowering alleles.</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06552a4b792277499d1f97dd583ddfee"><gtr:id>06552a4b792277499d1f97dd583ddfee</gtr:id><gtr:otherNames>Gregson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn><gtr:outcomeId>58c14cfb275ff4.14899954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EF69C2D-C4C3-41D7-B273-AE503C672F62</gtr:id><gtr:title>Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/113cc7e7df5287e13471822ad7fcaea6"><gtr:id>113cc7e7df5287e13471822ad7fcaea6</gtr:id><gtr:otherNames>Di Angelantonio E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a2fd9316888f5.40054330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AEAF505-5DF5-48DB-AC70-1302358C59C6</gtr:id><gtr:title>Increased DNA methylation variability in type 1 diabetes across three immune effector cell types.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b159c2fdc40bd9f1b680388b2982bc9d"><gtr:id>b159c2fdc40bd9f1b680388b2982bc9d</gtr:id><gtr:otherNames>Paul DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>588b668b3e7e72.31728163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40DF979D-542F-4C64-8CB5-D95CEC728F6C</gtr:id><gtr:title>Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/360a808324aad78098cb2db35a75a186"><gtr:id>360a808324aad78098cb2db35a75a186</gtr:id><gtr:otherNames>Haycock PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn><gtr:outcomeId>58c14d965dc2d1.49937808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01CEB47C-8C61-4F28-A38F-B551031DABC0</gtr:id><gtr:title>Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbfd9fb6e692d07596464ca94848bf67"><gtr:id>fbfd9fb6e692d07596464ca94848bf67</gtr:id><gtr:otherNames>Chen L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>58c14cfad383a5.99067999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4875F866-97E1-40AC-9562-E3BAE4CFBE5F</gtr:id><gtr:title>Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbca6510bdfa10166be62b369cdd718f"><gtr:id>bbca6510bdfa10166be62b369cdd718f</gtr:id><gtr:otherNames>Zanoni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>58c14b8dce1953.47813008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E441707-BDC3-4FD1-AB60-255D986DD075</gtr:id><gtr:title>Correlation of an epigenetic mitotic clock with cancer risk.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf9c2d3260e115f51a5ebf8d4d07d149"><gtr:id>bf9c2d3260e115f51a5ebf8d4d07d149</gtr:id><gtr:otherNames>Yang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58c14ca8bbf427.91270607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B652066-3751-4CAA-B480-FDAD3A0A4179</gtr:id><gtr:title>Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c14ca9b29c77.92291132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9467FDD-6880-43B1-805B-842B48FE31D6</gtr:id><gtr:title>Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/912b30d31656b2b1028d2418b3ec3190"><gtr:id>912b30d31656b2b1028d2418b3ec3190</gtr:id><gtr:otherNames>Singh T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>585d51e72061f2.40996907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEE580D4-2941-4D2E-8DEC-39824AFEBAF7</gtr:id><gtr:title>Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02bac0ee896543d3e23e64b1b65f0d59"><gtr:id>02bac0ee896543d3e23e64b1b65f0d59</gtr:id><gtr:otherNames>Sifrim A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>585d673c7efbb1.38130524</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DA77EC2-378A-4456-A466-88814998BAF6</gtr:id><gtr:title>Platelet function is modified by common sequence variation in megakaryocyte super enhancers.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fe5cc477bfbd16b54e3b4eb0082d7d5"><gtr:id>2fe5cc477bfbd16b54e3b4eb0082d7d5</gtr:id><gtr:otherNames>Petersen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a35dc00bd2264.28685468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>869AFDA8-0201-4EC5-BCB7-6435F02C7EDD</gtr:id><gtr:title>Bias due to participant overlap in two-sample Mendelian randomization.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn><gtr:outcomeId>585d31a2e14c63.74721555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B9B7655-A55B-4E7C-9AD6-5DD85D4B291A</gtr:id><gtr:title>Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis</gtr:title><gtr:parentPublicationTitle>The Lancet Diabetes &amp; Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c14d384b5a87c9bc3c358b7461f53714"><gtr:id>c14d384b5a87c9bc3c358b7461f53714</gtr:id><gtr:otherNames>Willeit P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c156769f3661.18268623</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2A3F1D2-DC53-4F4E-AFC6-53E2070E2856</gtr:id><gtr:title>Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f4e2610836a71803b87994e3e46760d"><gtr:id>8f4e2610836a71803b87994e3e46760d</gtr:id><gtr:otherNames>Gage SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>58c14cfb002176.90837042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E98C9906-F56D-4A62-B7E5-D6F98E83C87B</gtr:id><gtr:title>A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4069f6f80abc3dca900b1ffc9ba77f6f"><gtr:id>4069f6f80abc3dca900b1ffc9ba77f6f</gtr:id><gtr:otherNames>Scott RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>58c14c266d57c2.70567109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>425E28C4-3B85-4CB0-9884-093A803A2583</gtr:id><gtr:title>A review of published analyses of case-cohort studies and recommendations for future reporting.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02cdd1b81d6df42a82ec19819c9751dd"><gtr:id>02cdd1b81d6df42a82ec19819c9751dd</gtr:id><gtr:otherNames>Sharp SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e03667b0eb66.38071877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C48C3FD-B4E5-4CE1-90B2-5A9DDD9E2917</gtr:id><gtr:title>Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef3dd8d7b6622717fa234ee9778dc93f"><gtr:id>ef3dd8d7b6622717fa234ee9778dc93f</gtr:id><gtr:otherNames>Wheeler GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>5a2fd74e4d6094.02279847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3CCC729-0492-460D-867F-777022F241DD</gtr:id><gtr:title>The genetic architecture of type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02f1c0ac4ac1ce215e6ad458834e0672"><gtr:id>02f1c0ac4ac1ce215e6ad458834e0672</gtr:id><gtr:otherNames>Fuchsberger C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>585d6739ced115.33486343</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7BFC459-316E-466D-BC0F-93B07C8E0F06</gtr:id><gtr:title>Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/113cc7e7df5287e13471822ad7fcaea6"><gtr:id>113cc7e7df5287e13471822ad7fcaea6</gtr:id><gtr:otherNames>Di Angelantonio E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c1567644f875.69604136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F19E5321-839D-496C-83D6-E187D8767A9D</gtr:id><gtr:title>Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58d0b8672f7dcf2671bedbf1649f0bb0"><gtr:id>58d0b8672f7dcf2671bedbf1649f0bb0</gtr:id><gtr:otherNames>Howson JMM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a6d9704198b86.87487773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99E71D20-C63F-416A-8BBA-5A1F97D30A93</gtr:id><gtr:title>Genome-Wide Association Analysis of Young-Onset Stroke Identifies a Locus on Chromosome 10q25 Near HABP2.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13c5ab0757ef09129146c55e2c84906c"><gtr:id>13c5ab0757ef09129146c55e2c84906c</gtr:id><gtr:otherNames>Cheng YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>58c14d9637aa60.17411181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E6A4233-7121-4858-8A11-3F735A673624</gtr:id><gtr:title>Comparative validity of vitamin C and carotenoids as indicators of fruit and vegetable intake: a systematic review and meta-analysis of randomised controlled trials.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/783a1a1910d70519c37242956f10c439"><gtr:id>783a1a1910d70519c37242956f10c439</gtr:id><gtr:otherNames>Pennant M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn><gtr:outcomeId>56e032e77fe699.24109088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59387F53-8D6C-42E1-8FBA-3576F2AAC1AA</gtr:id><gtr:title>Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis.</gtr:title><gtr:parentPublicationTitle>JAMA cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea1e5ba889fd0cca140aeff5b41e4684"><gtr:id>ea1e5ba889fd0cca140aeff5b41e4684</gtr:id><gtr:otherNames>Muka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c14ca88fc346.00023804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D9CD5B4-F8DC-4A03-ADCA-15D4FB0D94FF</gtr:id><gtr:title>Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/590c8a9618b273cc7c1e0848dd49db27"><gtr:id>590c8a9618b273cc7c1e0848dd49db27</gtr:id><gtr:otherNames>Lotta LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>58c14ca8e64510.80752384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43054DB8-4DAF-4A36-9971-E9FEAD542A23</gtr:id><gtr:title>The role of epigenetic modifications in cardiovascular disease: A systematic review.</gtr:title><gtr:parentPublicationTitle>International journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea1e5ba889fd0cca140aeff5b41e4684"><gtr:id>ea1e5ba889fd0cca140aeff5b41e4684</gtr:id><gtr:otherNames>Muka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0167-5273</gtr:issn><gtr:outcomeId>58c14c264662d0.46885236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C90EA68D-C45E-447F-909A-C17D799F6AFA</gtr:id><gtr:title>PhenoScanner: a database of human genotype-phenotype associations.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f01fc7d80dc77023aafc31741f1e082"><gtr:id>4f01fc7d80dc77023aafc31741f1e082</gtr:id><gtr:otherNames>Staley JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>58c14ca96cecd7.31043335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B44FD91-884A-4E41-9615-4E1FB1789C3D</gtr:id><gtr:title>Investigating causality in the association between 25(OH)D and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ae09499f509debb276bcc0365bb8918"><gtr:id>0ae09499f509debb276bcc0365bb8918</gtr:id><gtr:otherNames>Taylor AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c14c261f9038.69146921</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>212382EA-4E45-4552-8755-C4BBC4B618A5</gtr:id><gtr:title>Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f01fc7d80dc77023aafc31741f1e082"><gtr:id>4f01fc7d80dc77023aafc31741f1e082</gtr:id><gtr:otherNames>Staley JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn><gtr:outcomeId>5a2fd755dd8652.27178514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8E573ED-AAE3-469B-9F13-0BA060E10426</gtr:id><gtr:title>Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb094f6bdc37c8484868410c6dce353d"><gtr:id>eb094f6bdc37c8484868410c6dce353d</gtr:id><gtr:otherNames>Kato N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56e0327ac6ebc0.21214158</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800270</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>